• Press Releases
    • 08/02/22
      Bioengineered Head Device Stops Alzheimer’s Memory Loss for 2 1⁄2 Years
    • 06/06/22
      Groundbreaking Alzheimer’s Treatment Study
    • 03/24/22
      NeuroEM Therapeutics Awarded $2.2M Grant from National Institute on Aging for Promising Device Against Alzheimer’s Disease
    • 10/28/20
      First-Ever Treatment Shown to Reverse Alzheimer’s Earns NeuroEM Therapeutics FDA Breakthrough Device Status
    • 09/16/19
      Alzheimer’s Memory Loss Reversed by New Head Device Using Electromagnetic Waves
    • 01/08/19
      NeuroEM Therapeutics Announces Completion of Clinical Trial Testing Its Novel Head Device Against Alzheimer’s Disease
    • 07/28/17
      Alzheimer’s Clinical Trial Begins with Pioneering Medical Device
    • 12/08/16
      National Institutes of Health Bestows Grant to NeuroEM Therapeutics and Arizona State University for Collaborative Research in Alzheimer’s Disease
    • 11/23/16
      NeuroEM Therapeutic’s CEO provides keynote address at Australian conference on biologic effects of electromagnetic exposure
    • 05/02/16
      Angel Investment Forum Provides “Series Seed” Funding to NeuroEM Therapeutics to Support Development of Medical Device against Alzheimer’s Disease